Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions.
Celebrating 90 years of innovation #UCB90
Twitter Feed
-
Thank you! it was great to celebrate surrounded by so many esteemed guests. @DBoBruessel #UCB90 https://t.co/hFODtTvoty
— UCB News (@ucb_news) 14.12.2018 -
Guest were duly impressed by the wearable technology on display. Thank you for the great partnership @byteflies #UCB90 https://t.co/raZgPanki0
— UCB News (@ucb_news) 14.12.2018 -
Thank you for joining us yesterday at our 90 year celebration. We were honored to have you with us. @alisonrosefco #UCB90 https://t.co/JhleGGPjm6
— UCB News (@ucb_news) 14.12.2018
Highlights
At UCB, we take our responsibility to the planet very seriously.
UCB Ventures, a strategic corporate venture fund established in 2017 to further strengthen UCB’s ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases, has announced its first direct investment.
